Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Linden Thomas Advisory Services LLC

Linden Thomas Advisory Services LLC boosted its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 20.5% in the fourth quarter, Holdings Channel.com reports. The firm owned 910 shares of the biotechnology company’s stock after acquiring an additional 155 shares during the period. Linden Thomas Advisory Services LLC’s holdings in Axon Enterprise were worth $541,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. Geneos Wealth Management Inc. grew its holdings in Axon Enterprise by 630.0% during the 4th quarter. Geneos Wealth Management Inc. now owns 1,847 shares of the biotechnology company’s stock valued at $1,098,000 after purchasing an additional 1,594 shares in the last quarter. Dynamic Advisor Solutions LLC grew its holdings in Axon Enterprise by 35.6% during the 4th quarter. Dynamic Advisor Solutions LLC now owns 3,246 shares of the biotechnology company’s stock valued at $1,929,000 after purchasing an additional 852 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. grew its holdings in Axon Enterprise by 56.2% during the 4th quarter. Harel Insurance Investments & Financial Services Ltd. now owns 5,867 shares of the biotechnology company’s stock valued at $3,487,000 after purchasing an additional 2,111 shares in the last quarter. Zweig DiMenna Associates LLC acquired a new stake in Axon Enterprise during the 4th quarter valued at $4,606,000. Finally, Berbice Capital Management LLC acquired a new stake in Axon Enterprise during the 4th quarter valued at $59,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on AXON shares. Needham & Company LLC raised their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. JMP Securities increased their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. Northland Securities increased their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Finally, Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One investment analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $504.92.

Axon Enterprise Trading Down 0.5 %

Axon Enterprise stock opened at $610.32 on Monday. The firm’s 50-day moving average is $617.65 and its 200-day moving average is $472.00. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a 1 year low of $247.04 and a 1 year high of $698.67. The company has a market cap of $46.54 billion, a P/E ratio of 157.71, a PEG ratio of 6.09 and a beta of 1.04.

Insider Activity at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of Axon Enterprise stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the sale, the director now owns 2,392 shares in the company, valued at approximately $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 50,545 shares of company stock worth $30,721,337 in the last ninety days. 6.10% of the stock is owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.